March 2020 – Kybora

Home
About Us
Services
News Feed
Contact

Home
About Us
Services
News Feed
Contact

Russian Federation Pharma – March 2020 update

June 8, 2020

1 comment

News

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular updates and networking

Recent blog post.

KYBORA is attending Bio Partnering at JPM

Posted: 1 month ago
Russian Federation Pharma – March 2020 update

Posted: 7 months ago
KYBORA Sponsors the Bio Latin America Conference Again

Posted: 8 months ago
Is China High Enough on Your Priority List?

Posted: 8 months ago
KYBORA successfully helps Stada license Xlucane to Bausch Health

Posted: 8 months ago

Tags.

Bausch Health biopharma biotechnology China Conference globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

How can we help you succeed?

We want to learn more about your strategic, fundraising, business, and corporate development needs.

Tell us about your needs!

KYBORA is an international advisory firm whose mission is to help life sciences companies succeed by offering optimal M&A, licensing, fundraising and strategic consulting services globally.

Pages.

About Kybora
Our Sectors
Our Team
Global Presence

Success Stories
News Feed
Contact Us

Recent blog post.

KYBORA is attending Bio Partnering at JPM

Posted: 1 month ago
Russian Federation Pharma – March 2020 update

Posted: 7 months ago
KYBORA Sponsors the Bio Latin America Conference Again

Posted: 8 months ago

Terms of service | Privacy policy

Recent blog post.

Tags.

TYPE & ENTER: